经皮椎体成形术治疗骨质疏松性椎体压缩骨折

目的　探讨椎体成形术治疗骨质疏松性椎体压缩骨折的早期临床效果。方法　对 1 8例骨质疏松性椎体压缩骨折病人的2 0个椎体 ,经皮椎弓根向椎体内穿针并注入聚甲基丙烯酸甲酯 (PMMA)。结果　 1 8例病人平均每个椎体注入骨水泥 6 5ml,X线检查骨水泥充盈良好 ,骨折复位满意。术后 1 2h至 3d ,疼痛明显减轻或消失 ,应用视觉模拟评分法测试疼痛缓解 81 % ,术中术后无明显并发症出现。对 1 6例病人随访 3～ 6个月 ,疼痛未复发 ,椎体形态未见改变。结论　经皮椎体成形术治疗骨质疏松性椎体压缩骨折 ,能够迅速缓解疼痛 ,增加椎体的稳定性 ,是安全有效的微创技术     

经皮椎体成形术治疗骨质疏松性椎体压缩骨折

目的：探讨椎体成形术治疗骨质疏松性椎体压缩骨折的早期临床效果。方法：对18例骨质疏松性椎体压缩骨折病人的20个椎体，经皮椎弓根向椎体内穿针并注入聚甲基丙烯酸甲酯（PMMA）。结果：18例病人平均每个椎体注入骨水泥6．5ml，X线检查骨水泥充盈良好，骨折复位满意。术后12h至3d，疼痛明显减轻或消失，应用视觉模拟评分法测试疼痛缓解81％，术中术后无明显并发症出现。对16例病人随访3－6个月，疼痛未复发，椎体形态未见改变。结论：经皮椎体成形术治疗骨质疏松性椎体压缩骨折，能够迅速缓解疼痛，增加椎体的稳定性，是安全有效的微创技术。     

经皮椎体成形术治疗骨质疏松脊柱压缩骨折

目的经皮椎体成形术(PercutaneousVertebroplastyPVP)治疗骨质疏松脊柱骨折的疗效和探讨。方法自2004年2月-2005年2月采用经皮椎体成形术治疗骨质疏松脊柱压缩骨折(os-teoporoticvertebralcompressionfractures,OVCF)10例13椎,均为后壁完整的持续疼痛性脊柱压缩骨折。手术过程为经双侧椎弓根穿刺后,以专用注入系统注入骨水泥强化椎体。观察术后症状改善情况。结果10例患者手术均顺利完成,在术后24小时内疼痛明显缓解,所有病例均未出现骨水泥渗漏及并发症。结论经皮椎体成形术作为治疗骨质疏松脊柱压缩骨折的新型微创技术,能迅速缓解疼痛,改善脊柱功能。     

经皮椎体成形术后心脏水泥栓塞1例并文献分析

<正>经皮椎体成形术(percutaneous vertebroplasty,PVP)是治疗骨质疏松性椎体压缩骨折(osteoporoticvertebral compression fracture, OVCF)的一种微创外科治疗方法,它通过将聚甲基丙烯酸甲酯(PMMA)骨水泥经皮注入压缩椎体,可以增加椎体强度及椎体稳定性,并能够迅速缓解疼痛。然而,骨水泥渗入静脉     

经皮椎体成形术治疗骨质疏松性椎体压缩骨折

经皮椎体成形术(percutaneous vertebroplasy，PV)是近年来脊柱外科发展的一项新的微创技术，它通过经皮向压缩骨折的椎体内注入填充物(如骨水泥等)，来增强稳定压缩骨折的椎体，减轻疼痛，是1987年法国Galibert等首先报道用于治疗椎体血管瘤，Deramond等将此技术用于椎体肿瘤及骨质疏松性椎体压缩骨折的治疗，     

骨填充网袋椎体成形术与PKP治疗骨质疏松性胸腰椎压缩骨折的疗效比较

目的比较骨填充网袋椎体成形术和经皮椎体后凸成形术(PKP)治疗骨质疏松性椎体压缩骨折的临床疗效。方法回顾性分析自2015-01—2017-05诊治的57例骨质疏松性胸腰椎压缩骨折,27例行PKP治疗(PKP组),30例行骨填充网袋椎体成形术治疗(网袋组)。结果与PKP组比较,网袋组骨水泥注入时透视次数更少,骨水泥注入量更大,而且骨水泥注入后椎体高度恢复程度优于PKP组,差异有统计学意义(P 0.05)。但2组手术时间、术后疼痛改善程度、骨水泥注入前椎体高度恢复程度比较差异无统计学意义(P0.05)。57例均获得随访,随访时间平均11.6(6～25)个月。网袋组无骨水泥椎体外渗漏,PKP组5例出现骨水泥渗漏;网袋组骨水泥渗漏发生率低于PKP组,差异有统计学意义(P 0.05)。结论与PKP比较,骨填充网袋椎体成形术治疗骨质疏松性胸腰椎压缩骨折同样具有微创和缓解疼痛的优点,同时在恢复椎体高度、减少骨水泥渗漏甚至预防骨水泥-骨界面再骨折方面具有优势。     

PKP和PVP治疗骨质疏松性椎体压缩骨折的疗效

目的比较经皮椎体成形术(PVP)与经皮椎体后凸成形术(PKP)治疗骨质疏松性椎体压缩骨折的疗效。方法将58例骨质疏松性椎体压缩骨折患者按照治疗方法分为PVP组和PKP组,各29例。比较两组手术时间、骨水泥注入量、骨水泥渗漏率、Cobb角和疼痛VAS评分。结果两组患者均获得随访,时间5～18个月。手术时间PVP组少于PKP组,骨水泥注入量及Cobb角恢复程度PKP组多(高)于PVP组,差异均有统计学意义(P 0. 05)。两组患者术后疼痛均较术前明显改善(P 0. 05),两组间比较差异无统计学意义(P0. 05)。骨水泥渗漏率PKP组低于PVP组,但差异无统计学意义(P 0. 05)。结论 PVP和PKP治疗骨质疏松性椎体压缩骨折均能迅速稳定椎体骨折,缓解疼痛。PVP较PKP手术时间短、骨水泥用量少,而PKP恢复椎体Cobb角更具有优势。     

经皮椎体成形术治疗老年骨质疏松性椎体压缩骨折

目的 探讨经皮椎体成形术治疗老年骨质疏松性椎体压缩骨折的临床效果。方法 对20例老年骨质疏松性椎体压缩骨折病人的27个椎体，经皮经椎弓根向椎体内穿刺并注入聚甲基丙烯酸甲醇(PMMA)，测量并计算术前和术后椎体前／后缘高度比值。结果 20例病人平均每个椎体注入量为5．8ml，经x线检查骨水泥充盈良好。术后4—6h疼痛开始缓解，无显危害性并发症发生。术前和术后椎体前／后缘高度比值无显性差异。对19例病人随访3-8个月，疗效评价按WHO标准CR PR率为100％。结论 经皮椎体成形术是一种有效的微创治疗技术。能迅速缓解老年骨质疏松性椎体压缩骨折所致的疼痛，加固椎体。增强脊柱稳定性。     

PVP与PKP治疗骨质疏松性椎体压缩骨折的疗效比较

目的比较经皮椎体成形术(Percutaneous vertebro plasty,PVP)与经皮椎体后凸成形术(Percutaneous kyphoplasty,PKP)治疗骨质疏松性椎体压缩骨折的临床疗效。方法回顾性分析自2016-01—2020-11诊治的82例骨质疏松性椎体压缩骨折,41例采用PKP治疗(PKP组),41例采用PVP治疗(PVP组),比较2组手术时间、骨水泥注入量、骨水泥渗漏情况,比较2组术后3个月疼痛VAS评分、ODI指数、伤椎前缘高度、伤椎Cobb角。结果 2组均顺利完成手术并获得至少3个月的随访。PKP组骨水泥注入量较PVP组多,骨水泥渗漏数较PVP组少,手术时间较PVP组长,差异有统计学意义(P0.05)。术后3个月2组疼痛VAS评分、ODI指数比较差异无统计学意义(P0.05);PKP组伤椎前缘高度较PVP组大,伤椎Cobb角较PVP组小,差异有统计学意义(P0.05)。结论骨质疏松性椎体压缩骨折采用PVP与PKP治疗均能显著减轻疼痛并促进术后快速康复,PKP在恢复伤椎高度、矫正椎体后凸畸形的效果优于PVP,且能减少骨水泥渗漏率。     

高黏度骨水泥经皮椎体成形术与经皮椎体后凸成形术治疗骨质疏松压缩骨折的临床疗效观察

[目的]探讨高黏度骨水泥经皮椎体成形术与经皮椎体后凸成形术两种疗法治疗老年骨质疏松性椎体压缩骨折的疗效。[方法]将63例老年骨质疏松性单一椎体压缩骨折患者随机分为两组,分别采用PKP和高黏度骨水泥经皮椎体成形术治疗,记录两组患者术前术后VAS评分、椎体高度以及两种手术方式的骨水泥注入量、手术出血量、手术时间和骨水泥渗漏发生率,对所得结果进行统计学分析。[结果](1)两组患者手术前后VAS评分改善值、平均骨水泥注入量、骨水泥渗漏发生率比较差异没有统计学意义(P0.05);(2)高黏度骨水泥经皮椎体成形术组的手术出血量、手术时间少于PKP组且有统计学意义(P0.05);(3)PKP组术后椎体高度恢复优于高黏度骨水泥经皮椎体成形术组且有统计学意义(P0.05);(4)术后影像学资料比较,PKP组患者骨水泥分布集中,密度较高;高黏度骨水泥组患者骨水泥呈弥散状分布,密度相对较低。[结论]高黏度骨水泥经皮椎体成形术与PKP治疗老年性椎体压缩骨折均能有效缓解疼痛且效果相当,两者渗漏率无明显差别;PKP在椎体高度恢复方面具有优势,而高黏度骨水泥经皮椎体成形术的手术时间较短,出血量较少。     

经皮椎体成形术与椎体后凸成形术治疗胸腰椎压缩性骨折的临床疗效比较

目的比较经皮椎体成形术与椎体后凸成形术治疗胸腰椎压缩性骨折的临床疗效。方法对98例胸腰椎压缩性骨折，根据手术方法不同分为椎体成形组和椎体后凸成形组。比较两组术前术后椎体前缘、中线、后缘高度变化，疼痛视觉模糊评分（VAS），手术时间，出血量等方面的差异。结果两组对椎体高度的恢复比较差异有统计学意义（P〈0．01），VAS、手术时间和出血量比较差异无统计学意义（P〉0．05）。结论经皮椎体成形术与椎体后凸成形术具有创伤小、手术时间短、出血量少等微创优点，而椎体后凸成形术具有较好的复位作用。     

三种术式治疗骨质疏松性椎体骨折的疗效分析

目的 :探讨经皮空心带侧孔椎弓根钉钉道骨水泥强化术、经皮椎体成形术(percutaneous vertebroplasty,PVP)和经皮椎体后凸成形术(percutaneous kyphoplasty,PKP)治疗骨质疏松性椎体骨折(osteoporotic vertebral compression fractures,OVCF)的临床疗效。方法 :对2012年5月至2013年11月收治的90例OVCF患者的临床资料进行回顾性分析,按手术方法的不同将其分为经皮空心带侧孔椎弓根钉钉道骨水泥强化组(A组)、PVP组(B组)和PKP组(C组),每组30例。术前、术后1 d、3个月、1年采用疼痛视觉模拟评分法(visual analogue scale,VAS)对患者疼痛缓解程度进行评定;通过影像学资料观察责任椎的椎体压缩率、矢状面Cobb角的变化。结果:所有患者手术顺利,无切口感染、深静脉血栓等并发症。末次随访时A组中有2例患者术后留有轻度腰背痛;B组残留中度腰背痛7例,重度腰背痛4例,术后椎体再骨折2例;C组残留中度腰背痛5例,重度腰背痛3例,术后椎体再骨折4例。术后3组VAS评分、责任椎的椎体高度压缩率、Cobb角均较术前明显改善(P0.05)。术后1 d、3个月、1年各项目A组与B、C两组比较差异有统计学意义(P0.05),B组与C组比较差异无统计学意义(P0.05)。术后1 d、3个月、1年各项目在A组内差异无统计学意义(P0.05);在B组与C组内差异有统计学意义(P0.05)。结论:PVP和PKP对OVCF患者术后即刻止痛效果较经皮空心带侧孔椎弓根钉钉道骨水泥强化术明显,但PVP、PKP患者术后随访均残留不同程度腰背痛;经皮空心带侧孔椎弓根钉钉道骨水泥强化术在恢复责任椎前缘高度和矫正椎体后凸畸形、减少术后残余腰背痛方面具有明显的优势。     

Vertebroplasty and Kyphoplasty in Spinal Trauma

Abstract Kyphoplasty and vertebroplasty have become recognized procedures for the treatment of vertebral fractures, especially in patients with osteoporosis. In most cases of osteoporotic spinal vertebral fracture in elderly patients, polymethylmethacrylate (PMMA) cement is used to fill the defect and stabilize the vertebral body. The techniques of vertebroplasty and kyphoplasty differ in the possibility of realignment and reconstruction of the vertebral body and spinal column. Long-term results in terms of integration of the cement and bioreactivity of the vertebral body are still lacking; so, these procedures are still no options in the treatment of younger patients. Vertebroplasty and kyphoplasty show different success in the management of fresh traumatic spine fractures. The acute traumatic vertebral fracture has to be classified sensitively, to find the right indication for cement augmentation. Mild acute compression fractures can be treated by vertebroplasty or kyphoplasty, severe compression and burst fractures by combination of internal fixation and kyphoplasty. The indications for use of biological or osteoinductive cement in spinal fracture management must still be regarded as restricted owing to the lack of basic biomechanical research data. Such cement should not be used except in clinical studies.     

椎体成形术与后凸成形术治疗老年陈旧性骨质疏松椎体压缩性骨折的相关问题探讨

目的:探讨椎体成形术(PVP)与后凸成形术(PKP)治疗老年陈旧性骨质疏松椎体压缩性骨折的疗效和安全性。方法:自2004年12月至2008年6月,采用PVP治疗28例(40椎)骨质疏松性椎体压缩性骨折,其中男11例(14椎),女17例(26椎);年龄70～91岁,平均72岁。骨折部位T5-L5。采用PKP治疗31例(43椎),男13例(18椎),女18例(25椎);年龄70～92岁,平均74岁;骨折部位T4-L5。术后采用疼痛视觉模拟评分(visualanaloguescale,VAS)、Oswestry功能评分、后凸Cobb角、椎体前中柱的平均高度及骨水泥的渗漏率等指标来评估两组疗效。结果:两组术后VAS评分和Oswestry功能评分都有明显下降,与术前相比有统计学差异(P0.01);两组间VAS评分和Oswestry功能评分降低值无统计学意义(P0.05)。两组后凸Cobb角及椎体前中柱的平均高度与术前比较差异无统计学意义(P0.05)。骨水泥渗漏率,PVP组3个椎体(7.5%),PKP组2个椎体(4.7%),但均无神经症状。两组比较差异无统计学意义(P0.05)。结论:PVP和PKP均能有效缓解老年陈旧性骨质疏松性椎体压缩性骨折所引起的疼痛,改善患者的脊柱功能,并且是一种安全有效的治疗方法。     

Balloon kyphoplasty versus percutaneous vertebroplasty for osteoporotic vertebral body compression fractures: clinical and radiological outcomes

BACKGROUND CONTEXTOsteoporotic vertebral body compression fracture are the commonest fractures amongst the other osteoporotic fracture sites. These fragility fractures are the result of low energy mechanical forces that that would not ordinarily result in fracture. Percutaneous vertebroplasty and balloon kyphoplasty has been widely used as minimally invasive procedures to treat painful vertebral compression fractures.PURPOSEAim of the present study was to evaluate radiological, clinical and functional outcome of patients with osteoporotic vertebral body fractures treated with Balloon Kyphoplasty and Vertebroplasty.STUDY DESIGNProspective cohort studyPATIENT SAMPLE40 patients (Male:15, Female: 25) with average age of 56 +/- 8 years diagnosed with osteoporotic vertebral body compression fracture on clinical and radiological evaluation with no neurological deficit and no other associated fractures were included.OUTCOME MEASURESOperative time, cost for the procedure, gain in vertebral body height, reduction in pain, ability to perform daily routine activities, risk of cement leakage and any other systemic complications were evaluated and compared in both the study groups.METHODSAll the patients underwent conventional Xray, MRI (to rule out acute from chronic fracture, to check compromise of spinal canal and calculate collapse in vertebral body height), Visual analog scaling for severity of pain and difficulty in daily routine activities by Oswestry disability index preoperatively. Post operative clinal, functional, radiological outcome and complications were compared in patients treated with percutaneous vertebroplasty and balloon kyphoplasty.RESULTThere was significant difference in intraoperative time period and procedure cost for the patients treated with Vertebroplasty(50.75min, 25k) in comparison to balloon kyphoplasty (71.95, 50k) with p value being < .001There was significant difference between preoperative and postoperative study parameters in both the study groups but there was no significant difference in post operative study parameters amongst both the study groups with p values >.05 for different parameters, 0.381(Gain in vertebral height), 0.108 (pain relief), 0.846(Oswestry disability index) and 0.197(risk of cement leakage)CONCLUSIONOur study suggested that percutaneous vertebroplasty requires less operative time and is more economical than balloon kyphoplasty. Increase in intraoperative time increases the risk of infection. Though the cases of Intraoperative operative cement leakage were more in percutaneous vertebroplasty but is was not significant. However the final radiological, clinical, functional outcome and overall complications were found to be similar in both the groups. Balloon kyphoplasty provided no added benefit over percutaneous vertebroplasty. A study with larger sample size will be needed to warrant one surgical procedure superior to other in the treatment of osteoporotic vertebral body compression fracture.     

Percutaneous vertebral augmentation.

BACKGROUND CONTEXT: With the aging of the population, painful osteoporotic compression fractures are becoming more common. PURPOSE: To review the physiologic implications of these injuries as well as treatment options and outcomes, especially with reference to newer, percutaneous "augmentation" procedures, that is, vertebroplasty and kyphoplasty. STUDY DESIGN/SETTING: A literature review. METHODS: No direct, randomized studies comparing vertebroplasty, kyphoplasty and standard, nonoperative care are available. RESULTS: The growing literature suggests a role for kyphoplasty and vertebroplasty in the management of patients with intractable pain or progressive vertebral collapse after vertebral compression fracture. Both procedures likely offer similar rates of pain relief. Kyphoplasty, although more expensive, may allow fracture reduction. The void created with the balloon tamp allows a more viscous cement to be applied, thereby decreasing the risk of extravasation. CONCLUSIONS: More study is required to understand the ideal role of these new techniques in the management of spinal osteoporosis and associated fractures. However, for carefully selected cases, current data suggest that the complication rates are low and pain relief can be profound.     

经皮椎体成形术与经皮后凸成形术治疗胸腰椎压缩性骨折

目的探讨经皮椎体成形术（percutaneous vertebroplasty,PVP）及经皮后凸成形术（percutaneous kyphoplasty,PKP）治疗骨质疏松性胸腰椎压缩性骨折的临床疗效。方法回顾性分析行PVP或PKP治疗骨质疏松性胸腰椎骨折的患者38例,共54个节段,临床均表现为腰背部痛,且无神经症状及体征。其中33个节段采用PKP治疗,21个节段采用PVP治疗。结果术后1个月门诊随访患者疼痛视觉模拟量表（visual analogue scale,VAS）与活动能力评分均较术前明显改善,未发生骨水泥渗漏及神经受损等症状。术后3个月复查未见椎体压缩。结论应用PVP或PKP治疗骨质疏松性胸腰椎压缩性骨折应用PVP或PKP可有效缓解疼痛,恢复椎体高度。     

Percutaneous vertebral augmentation: an elevation in adjacent-level fracture risk in kyphoplasty as compared with vertebroplasty.

BACKGROUND CONTEXT: Osteoporotic vertebral compression fractures (VCFs) are being increasingly treated with minimally invasive bone augmentation techniques such as kyphoplasty and vertebroplasty. Both are reported to be an effective means of pain relief; however, there may be an increased risk of developing subsequent VCFs after such procedures. PURPOSE: The purpose of this study was to compare the effectiveness and complication profile of kyphoplasty and vertebroplasty in a single patient series. STUDY DESIGN/SETTING: A clinical series of 36 patients with VCFs treated by vertebral augmentation procedures was retrospectively analyzed for surgical approach, volume of cement injected, cement extravasation (symptomatic and asymptomatic), the occurrence of subsequent adjacent level fracture, and pain relief. PATIENT SAMPLE: Thirty-six patients with 46 VCFs underwent either kyphoplasty or vertebroplasty after failing conservative therapy. The mean patient age was not significantly different between the kyphoplasty group (70; range, 46-83) and vertebroplasty group (72; range, 38-90) (p=.438). OUTCOME MEASURES: Outcomes were assessed by using self-report measures (a comparative pain rating scale) and physiologic measures (pre- and postoperative radiographs). METHODS: Thirty-six patients with VCFs underwent 46 augmentation procedures (17 patients had 20 fractures treated via kyphoplasty, and 19 patients had 26 fractures treated via vertebroplasty). Seventeen patients in this series underwent kyphoplasty using standard techniques involving bone void creation with balloon tamps, followed by cement injection. Nineteen patients underwent a percutaneous vertebroplasty procedure using a novel cannulated, fenestrated bone tap developed to direct cement anteriorly into the vertebral body to avoid backflow of cement onto neural elements. RESULTS: Pain improvement was seen in >90% of patients in both groups. Mean cement injection per vertebral body was 4.65 mL and 3.78 mL for the kyphoplasty and vertebroplasty groups, respectively (p=.014). Ninety-five percent of the kyphoplasty procedures were performed bilaterally, whereas only 19% of the vertebroplasty procedures required bilateral augmentation (p<.001). There was no cement extravasation resulting in radiculopathy, or myelopathy in either group. Asymptomatic cement extravasation was seen in 5 of 46 (11%) of the total series (3/20 [15%] and 2/26 [7.7%] of kyphoplasty and vertebroplasty, respectively) (p=.696). Within a 3-month period, there were 5 new adjacent level fractures seen in 3 patients who underwent a kyphoplasty procedure (5/20 [25%]) and none in the vertebroplasty group (p<.05). CONCLUSIONS: Vertebroplasty appears to offer a comparable rate of postoperative pain relief as kyphoplasty while using less bone cement more often via a unilateral approach and without the attendant risk of adjacent level fracture.     

骨盆牵引复位联合单侧入路椎体成形术治疗胸腰椎压缩骨折

目的探讨骨盆牵引复位联合单侧入路椎体成形术治疗胸腰椎压缩性骨折的临床效果。方法 2003年11月～2008年8月对116例受伤3周以内胸腰椎压缩性骨折,先行骨盆牵引复位压缩的椎体,然后再行单侧入路椎体成形术,观察压缩骨折的复位程度、疼痛缓解以及骨水泥渗漏情况。结果 7例椎体周围有少许骨水泥渗出,2例椎管内少量泄漏,2例静脉注入,骨水泥渗漏率9.5%(11/116),均无临床症状,无过敏反应。1例术后短暂发热,经对症处理后缓解。116例随访6个月～5.5年,平均3年6个月,疼痛缓解有效率92.2%(107/116);骨折复位情况:椎体高度恢复60%～95%,平均85.4%;椎管直径恢复情况:90%～100%,平均93.6%。结论骨盆牵引对于急性胸腰椎压缩性骨折有较高的复位率,并能够很好矫正后凸畸形,联合单侧入路椎体成形术,使受伤椎体的强度立即得到加强,具有创伤小、疗效好、并发症少、价格低廉,值得推广应用。     

PKP与高粘度骨水泥PVP治疗骨质疏松性椎体压缩骨折的疗效比较

目的比较经皮椎体后凸成形术(PKP)与高粘度骨水泥经皮椎体成形术(PVP)治疗骨质疏松性椎体压缩骨折的临床效果。方法纳入自2012-02—2016-04诊治的100例骨质疏松性椎体压缩骨折,行PKP治疗者50例(PKP组),行高粘度骨水泥PVP治疗者50例(PVP组)。比较2组术后VAS评分、ODI指数、伤椎前缘高度压缩比值、伤椎前缘高度恢复比值,以及骨水泥渗漏率。结果 2组术后VAS评分、ODI指数、伤椎前缘高度压缩比值较术前明显降低,差异有统计学意义(P0.05)。但2组术后各时间点VAS评分、ODI指数差异无统计学意义(P0.05)。PKP组术后3 d、12个月伤椎前缘高度压缩比值低于PVP组,伤椎前缘高度恢复比值高于PVP组,差异有统计学意义(P0.05)。PVP组骨水泥渗漏发生率低于PKP组,差异有统计学意义(P0.05)。结论 PKP、高粘度骨水泥PVP治疗骨质疏松性椎体压缩骨折可明显减轻患者疼痛,改善患者功能障碍程度,PKP术后椎体高度恢复效果更优,而高粘度PVP骨水泥渗漏率较低。